Abstract
For centuries, lichens have been used in traditional medicine and their use persists to the present day in some parts of the world. Depsidones are one of the classes of secondary metabolites which are mostly produced in lichens. Lichen depsidones have been reported to possess many biological activities, such as antitumor and antimicrobial activities. In order to point out the pharmacological potential of this class of compounds, the present article reviews the structure and biological properties of the known lichen depsidones. The biosynthesis of depsidones and the relationship between their chemical structure and biological activity is also discussed.
Keywords: Biological activity, biosynthesis, depsidones, lichen, structure-activity relationship, Cyrenespora cassiicola, Garcinisidones, M14 cell line, Vicanicin, Lobaric acid
Mini-Reviews in Organic Chemistry
Title:Lichen Depsidones as Potential Novel Pharmacologically Active Compounds
Volume: 9 Issue: 2
Author(s): Gordana Stojanovic, Igor Stojanovic and Andrija Smelcerovic
Affiliation:
Keywords: Biological activity, biosynthesis, depsidones, lichen, structure-activity relationship, Cyrenespora cassiicola, Garcinisidones, M14 cell line, Vicanicin, Lobaric acid
Abstract: For centuries, lichens have been used in traditional medicine and their use persists to the present day in some parts of the world. Depsidones are one of the classes of secondary metabolites which are mostly produced in lichens. Lichen depsidones have been reported to possess many biological activities, such as antitumor and antimicrobial activities. In order to point out the pharmacological potential of this class of compounds, the present article reviews the structure and biological properties of the known lichen depsidones. The biosynthesis of depsidones and the relationship between their chemical structure and biological activity is also discussed.
Export Options
About this article
Cite this article as:
Stojanovic Gordana, Stojanovic Igor and Smelcerovic Andrija, Lichen Depsidones as Potential Novel Pharmacologically Active Compounds, Mini-Reviews in Organic Chemistry 2012; 9 (2) . https://dx.doi.org/10.2174/157019312800604689
DOI https://dx.doi.org/10.2174/157019312800604689 |
Print ISSN 1570-193X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6298 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
New Antitumour Natural Products from Marine Red Algae: Covering the Period from 2003 to 2012
Mini-Reviews in Medicinal Chemistry Molecular Targets of Gemcitabine Action: Rationale for Development of Novel Drugs and Drug Combinations
Current Pharmaceutical Design Editorial [Hot topic: The Urokinase Receptor System as Strategic Therapeutic Target: Challenges for the 21st Century (Executive Guest Editor: Bernard Degryse)]
Current Pharmaceutical Design Paris polyphylla: Chemical and Biological Prospectives
Anti-Cancer Agents in Medicinal Chemistry Nilotinib Therapy in Chronic Myelogenous Leukemia: The Strength of High Selectivity on BCR/ABL
Current Drug Targets Development Course and an Application Strategy for Induced Pluripotent Stem Cells in Regenerative Medicine
Current Stem Cell Research & Therapy Phosphonomethoxyalkyl Analogs of Nucleotides
Current Pharmaceutical Design Aberrant Immunoglobulin Variations as Indicators of Eventual Clonal Changes in Symptomatic Multiple Myeloma Patients' Course
Current Cancer Therapy Reviews Pluripotent Stem Cells for Livestock Health and Production
Current Stem Cell Research & Therapy Current and Emerging Strategies in Bladder Cancer
Anti-Cancer Agents in Medicinal Chemistry Perspectives in Nanomedicine-Based Research Towards Cancer Therapies
Current Nanoscience Malignancy in Common Variable Immune Deficiency: Report of Two Rare Cases of Gastrointestinal Malignancy and a Review of the Literature
Cardiovascular & Hematological Disorders-Drug Targets Gedunin, A Neem Limonoid in Combination with Epalrestat Inhibits Cancer Hallmarks by Attenuating Aldose Reductase-Driven Oncogenic Signaling in SCC131 Oral Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Modulating Co-Stimulation During Antigen Presentation to Enhance Cancer Immunotherapy
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Small Molecule Tyrosine Kinase Inhibitors: The New Dawn for Cancer Therapy
Letters in Drug Design & Discovery ChemoImmunoModulation: Immune Regulation by the Antineoplastic Chemotherapeutic Agents
Current Medicinal Chemistry Regulatory Circuitries Coordinated by Transcription Factors and microRNAs at the Cornerstone of Hematopoietic Stem Cell Self-Renewal and Differentiation
Current Stem Cell Research & Therapy Transcriptome and Proteome Analyses of Drug Interactions with Natural Products
Current Drug Metabolism Curcumin: Structure-Activity Relationship Towards its Role as a Versatile Multi-Targeted Therapeutics
Mini-Reviews in Organic Chemistry Development of Novel Cardiovascular Therapeutics From Small Regulatory RNA Molecules - An Outline of Key Requirements
Current Pharmaceutical Design